Psychiatric medication prescriptions
| Prescription type, % | Overall n = 381 | Males n = 154 | Females n = 227 | Aged 0–6 years n = 37 | Aged 7–12 years n = 146 | Aged 13–17 years n = 198 | Male versus female P-valuea | Age categories P-valuea |
|---|---|---|---|---|---|---|---|---|
| Psychiatric: first year after diagnosisb | 10.5 | 8.4 | 11.9 | 2.7 | 7.5 | 14.1 | 0.36 | 0.03 |
| Psychiatric: second year after diagnosis | 8.4 | 7.1 | 9.3 | 2.7 | 4.1 | 12.6 | 0.59 | 0.01 |
| Psychiatric: 0–2 years after diagnosis | 13.6 | 9.7 | 16.3 | 5.4 | 8.2 | 19.2 | 0.09 | 0.004 |
| SSRI prescription: first year after diagnosis | 1.0 | 0.0 | 1.8 | 0.0 | 0.0 | 2.0 | 0.15 | 0.15 |
| SSRI: second year after diagnosis | 1.6 | 0.6 | 2.2 | 0.0 | 0.0 | 3.0 | 0.43 | 0.06 |
| SSRI: 0–2 years after diagnosis | 1.8 | 0.6 | 2.6 | 0.0 | 0.0 | 3.5 | 0.26 | 0.05 |
| Benzodiazepine: first year after diagnosis | 5.5 | 3.9 | 6.6 | 0.0 | 2.1 | 9.1 | 0.36 | 0.006 |
| Benzodiazepine: second year after diagnosis | 2.1 | 2.6 | 1.8 | 0.0 | 0.0 | 4.0 | 0.72 | 0.03 |
| Benzodiazepine: 0–2 years after diagnosis | 6.0 | 5.2 | 6.6 | 0.0 | 2.1 | 10.1 | 0.73 | 0.004 |
| Beta-blocker: first year after diagnosis | 8.7 | 6.5 | 10.1 | 0.0 | 0.0 | 16.7 | 0.29 | <0.001 |
| Beta-blocker prescription: second year after diagnosis | 2.1 | 2.0 | 2.2 | 0.0 | 0.0 | 4.0 | 1.00 | 0.04 |
| Beta-blocker prescription: 0–2 years after diagnosis | 9.2 | 6.5 | 11.0 | 0.0 | 0.0 | 17.7 | 0.19 | <0.001 |
↵a Percentages among males compared to females, percentages among age categories compared with χ2 test. These hypothesis tests are of exploratory nature, and are not corrected for multiple testing.
↵b ≥1 psychiatric prescriptions of ATC classification N05–N07. ATC = Anatomical Therapeutic Chemical. SSRI = selective serotonin reuptake inhibitor.